A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors

NCT03734926 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma
Cholangiocarcinoma
Gastric Cancer
Esophageal Cancer
Colorectal Cancer

Interventions

DRUG: ZSP1241

Sponsor

Guangdong Zhongsheng Pharmaceutical Co., Ltd.